Oxaliplatin as adjuvant therapy for colon cancer: updated results of NSABP C-07 trial, including survival and subset analyses.

By G. Yothers, M. O’connell, C. Allegra, J. Kuebler, L. Colangelo, N. Petrelli, N. Wolmark. Journal of Clinical Oncology, 2011

633 citations recorded by the source corpus.

Subfields: Cancer Research, Oncology

View Paper: https://www.semanticscholar.org/paper/0f7991f7415e34e26938b89ea4cf2e9c32a278b2

Citations in the corpus

• Localised Colon Cancer: ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up. (2020, neutral): “The benefit of these combinations over fluoropyrimidine monotherapy, the prior standard of care, has been demonstrated in three landmark trials: MOSAIC, NSABP C-07 and XELOXA.”